Sirona Biochem Corp V.SBM

Results are out on Sedar

[Pandora]

If anyone is interested.

[sakinny3]

Is it just me or do their figures always have some issues? In the MD&A item 1.5 shows the quarterly results, item 1.10 shows the results for the 9 months to end July. In my basic math, the 9 month data is only the results of Q1 and Q3 added together and is missing Q2. Something not right

[Tyromp]

I agree and had the same question

[Pandora]

So you're saying if the math was correct the total for 9 months should be $18,159 + $190,923 + $219,963 = $429,025  and not $238,122 as shown. Makes a mess of all other numbers then. Presumably they will shortly be issuing a correction. Presumably these are not audited.

[Tyromp]

Yes, or maybe the revenue from Q2 is moved to Q3? And therefore Q2 should be re-stated

[lscfa]

Fire the bums. Part-time bozos can't even add.....    

[MirrorWorldMan]

Quarter to quarter post launch revenue of a drug is a critical measure of consumer acceptance. Especially if it takes a couple of months to be effective. Its a little early to know how 1067 is doing in the marketplace, given that R + F ordered initial stock prior to launch and the dark spot corrector was launched mid March, with a tube lasting a long time in its current format and indication for

[skiboard09]

How much cash left ?    

[skiboard09]

Less then 200k. What is howie going to do to keep lights on? 

[PeterG]

announcing something big today after trading is closed? Who knows!!

[lscfa]

.  $250,000 per qtr from R+F + 5 million $0.18 warrants expire Oct 16. ($900,000).

[lscfa]

They don't even know how to present the no.s to show a more encouraging trend.....   Qtr ending Milestone Payment Sales to R+F Total Revenue Jul 21 0 219,963 219,963 Apr 21 63,325